{"created":"2023-05-15T09:57:42.754418+00:00","id":1554,"links":{},"metadata":{"_buckets":{"deposit":"e483ac3f-bdea-4fa1-ad1d-33523989dfe7"},"_deposit":{"created_by":5,"id":"1554","owner":"5","owners":[5],"pid":{"revision_id":0,"type":"depid","value":"1554"},"status":"published"},"_oai":{"id":"oai:miyazaki-u.repo.nii.ac.jp:00001554","sets":["72","72:30"]},"author_link":["7804","9245","9222"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2009-04","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"4","bibliographicPageEnd":"352","bibliographicPageStart":"347","bibliographicVolumeNumber":"98","bibliographic_titles":[{"bibliographic_title":"産婦人科治療","bibliographic_titleLang":"ja"},{"bibliographic_title":"Obstetrical and gynecological therapy","bibliographic_titleLang":"en"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"切迫早産の治療には,子宮収縮抑制剤が主に用いられる.しかし,欧米での検討では,その妊娠期間延長効果はたかだか48時間程度と報告され,母体搬送,もしくはステロイドの効果発現までの時間を稼ぐために short term で使用される.一方,本邦では妊娠期間の延長自体を目的に long term で使用される傾向にある.子宮収縮抑制剤の母体,胎児への副作用が報告されており,妊娠期間延長による benefit と薬剤の副作用による risk を考え投与する必要がある.","subitem_description_language":"ja","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"永井書店","subitem_publisher_language":"ja"}]},"item_10001_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00099457","subitem_source_identifier_type":"NCID"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0558471X","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"川越, 靖之","creatorNameLang":"ja"},{"creatorName":"カワゴエ, ヤスユキ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{},{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":"","affiliationNameIdentifierScheme":"ISNI","affiliationNameIdentifierURI":"http://www.isni.org/isni/"}],"affiliationNames":[{"affiliationName":"","affiliationNameLang":"ja"}]}],"creatorNames":[{"creatorName":"Sameshima, Hiroshi","creatorNameLang":"en"},{"creatorName":"鮫島, 浩","creatorNameLang":"ja"},{"creatorName":"サメシマ, ヒロシ","creatorNameLang":"ja-Kana"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"Kawagoe, Yasuyuki","creatorNameLang":"en"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-06-21"}],"displaytype":"detail","filename":"431.pdf","filesize":[{"value":"623.4 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"431.pdf","url":"https://miyazaki-u.repo.nii.ac.jp/record/1554/files/431.pdf"},"version_id":"c1aba789-5b4a-4816-b38a-56d89111c621"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"切迫早産, 子宮収縮抑制剤, 塩酸リトドリン, 硫酸マグネシウム","subitem_subject_language":"ja","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"切迫早産の薬物療法","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"切迫早産の薬物療法","subitem_title_language":"ja"},{"subitem_title":"Tocolytic therapy for preterm labor","subitem_title_language":"en"}]},"item_type_id":"10001","owner":"5","path":["72","30"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2010-05-24"},"publish_date":"2010-05-24","publish_status":"0","recid":"1554","relation_version_is_last":true,"title":["切迫早産の薬物療法"],"weko_creator_id":"5","weko_shared_id":2},"updated":"2024-01-30T04:24:06.766468+00:00"}